Brought to you by:
InterVene receives US FDA 510(k) clearance for Recana thrombectomy system
InterVene recently announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Recana thrombectomy catheter system, which is designed for the treatment of venous in-stent restenosis and native vessel obstructions. A press release notes…
Vein mapping rates show no sign of change two years after BEST-CLI, new study demonstrates
Vein mapping for lower extremity bypass in patients with chronic limb-threatening ischemia (CLTI) remains unchanged two years after the BEST-CLI, “revealing the difficulty in changing practice patterns based on new evidence,” according to the authors behind a new retrospective multicenter…
Anton Sidawy becomes president of American College of Surgeons
Former Society for Vascular Surgery (SVS) President Anton N. Sidawy, MD, FACS, DFSVS, became the 106th president of the American College of Surgeons (ACS) at the ACS Clinical Congress 2025 in Chicago earlier this month (Oct. 4–7). A professor of…
‘Ask not what vascular surgery can do for you… ask what it can do to you’
During his own recent presidential address on home turf, Patrick Muck, MD, invoked immortable words from the inaugural address of President John F. Kennedy to make a very serious point about radiation safety in vascular care: “Ask not what vascular…
Randomized data ‘debunks’ widely used negative pressure wound therapy
“How did an ineffective and costly intervention become routine care in the NHS [UK National Health Service]?” Ian Chetter, MBChB, chair of surgery at Hull York Medical School, University of Hull in Hull, England, posed at the 39th European Society…
Interim RAPID-PE study reveals ‘excellent’ safety data in first 50 patients
Prespecified interim analysis data from the first 50 patients in RAPID-PE have demonstrated “excellent safety” and “remarkably efficient lab times” in patients receiving on-the-table pharmacomechanical lysis without any post-procedure infusion with the Bashir endovascular catheter (Thrombolex) for the treatment of…
‘The patient is there to see me and my face’: Making shared decision-making central to vascular care
Matthew Corriere, MD, believes a major shift is needed in how clinicians communicate and make decisions with their patients. During the 2025 distinguished address given at the New England Society for Vascular Surgery (NESVS) annual meeting in Providence, Rhode Island…
Positive data show novel delayed-release diameter reduction technique in construction of PMEGs is viable
A novel physician-modified endograft (PMEG) technique for the treatment of thoracoabdominal and complex abdominal aortic aneurysms (TAAA and AAA) involving delayed-release diameter reduction to aortic size and shape—allowing for sequential target vessel cannulation—is safe and effective, according to a new…
TAMBE and TBE: Evolving experiences and piecing together channels of inquiry
New findings chronicling progress with both the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE)— approved by the Food and Drug Administration (FDA) last year—and Gore Tag thoracic branch endoprosthesis (TBE), which recently acquired a new indication for use in aortic zones…
Patient-facing literature from SVS found to exceed recommended reading level
A readability analysis of 15 publicly available patient education materials from the SVS found that all but three exceeded the 8th-grade reading level, the threshold at which the average adult in the U.S. reads. Additionally, all 15 breached the 6th-grade…